176 related articles for article (PubMed ID: 18648539)
1. Transcriptome alteration in the diabetic heart by rosiglitazone: implications for cardiovascular mortality.
Wilson KD; Li Z; Wagner R; Yue P; Tsao P; Nestorova G; Huang M; Hirschberg DL; Yock PG; Quertermous T; Wu JC
PLoS One; 2008 Jul; 3(7):e2609. PubMed ID: 18648539
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic mice.
How OJ; Larsen TS; Hafstad AD; Khalid A; Myhre ES; Murray AJ; Boardman NT; Cole M; Clarke K; Severson DL; Aasum E
Arch Physiol Biochem; 2007; 113(4-5):211-20. PubMed ID: 18158644
[TBL] [Abstract][Full Text] [Related]
3. In vivo metabolic phenotyping of myocardial substrate metabolism in rodents: differential efficacy of metformin and rosiglitazone monotherapy.
Shoghi KI; Finck BN; Schechtman KB; Sharp T; Herrero P; Gropler RJ; Welch MJ
Circ Cardiovasc Imaging; 2009 Sep; 2(5):373-81. PubMed ID: 19808625
[TBL] [Abstract][Full Text] [Related]
4. Exercise training does not correct abnormal cardiac glycogen accumulation in the db/db mouse model of type 2 diabetes.
Shearer J; Ross KD; Hughey CC; Johnsen VL; Hittel DS; Severson DL
Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E31-9. PubMed ID: 21386062
[TBL] [Abstract][Full Text] [Related]
5. Effect of rosiglitazone on the expression of cardiac adiponectin receptors and NADPH oxidase in type 2 diabetic rats.
Guo Z; Qin Z; Zhang R; Li J; Yin Y
Eur J Pharmacol; 2012 Jun; 685(1-3):116-25. PubMed ID: 22542658
[TBL] [Abstract][Full Text] [Related]
6. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
[TBL] [Abstract][Full Text] [Related]
7. Differential modulatory effects of rosiglitazone and pioglitazone on white adipose tissue in db/db mice.
Yang KJ; Noh JR; Kim YH; Gang GT; Hwang JH; Yang SJ; Yeom YI; Lee CH
Life Sci; 2010 Sep; 87(13-14):405-10. PubMed ID: 20723549
[TBL] [Abstract][Full Text] [Related]
8. Effects of rosiglitazone (PPAR γ agonist) on the myocardium in non-hypertensive diabetic rats (PPAR γ).
Abou Daya K; Abu Daya H; Nasser Eddine M; Nahhas G; Nuwayri-Salti N
J Diabetes; 2015 Jan; 7(1):85-94. PubMed ID: 24548695
[TBL] [Abstract][Full Text] [Related]
9. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
10. Characterization of local gut microbiome and intestinal transcriptome responses to rosiglitazone treatment in diabetic db/db mice.
Madsen MSA; Grønlund RV; Eid J; Christensen-Dalsgaard M; Sommer M; Rigbolt K; Madsen MR; Jelsing J; Vrang N; Hansen HH; Mikkelsen M
Biomed Pharmacother; 2021 Jan; 133():110966. PubMed ID: 33171401
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone treatment reversed depression- but not psychosis-like behavior of db/db diabetic mice.
Sharma AN; Elased KM; Lucot JB
J Psychopharmacol; 2012 May; 26(5):724-32. PubMed ID: 22331176
[TBL] [Abstract][Full Text] [Related]
12. Resolution of Inflammation by Resolvin D1 Is Essential for Peroxisome Proliferator-activated Receptor-γ-mediated Analgesia during Postincisional Pain Development in Type 2 Diabetes.
Saito T; Hasegawa-Moriyama M; Kurimoto T; Yamada T; Inada E; Kanmura Y
Anesthesiology; 2015 Dec; 123(6):1420-34. PubMed ID: 26492476
[TBL] [Abstract][Full Text] [Related]
13. A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone.
Verschuren L; Wielinga PY; Kelder T; Radonjic M; Salic K; Kleemann R; van Ommen B; Kooistra T
BMC Med Genomics; 2014 Jun; 7():35. PubMed ID: 24938300
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor.
Ihm SH; Chang K; Kim HY; Baek SH; Youn HJ; Seung KB; Kim JH
Basic Res Cardiol; 2010 May; 105(3):399-407. PubMed ID: 19902320
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy.
Zhang H; Saha J; Byun J; Schin M; Lorenz M; Kennedy RT; Kretzler M; Feldman EL; Pennathur S; Brosius FC
Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1071-81. PubMed ID: 18667486
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone Attenuates Memory Impairment in Aged Rat with Diabetes by Inhibiting NF-kappa B Signal Pathway Activation.
Fei L; Yong-Jun H; Zhang-Min M; Bing X; Shuang W; Qian-qian S; Jun L
Exp Clin Endocrinol Diabetes; 2015 Oct; 123(9):536-42. PubMed ID: 26285068
[TBL] [Abstract][Full Text] [Related]
18. The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.
Hwang J; Kleinhenz DJ; Rupnow HL; Campbell AG; Thulé PM; Sutliff RL; Hart CM
Vascul Pharmacol; 2007 Jun; 46(6):456-62. PubMed ID: 17337254
[TBL] [Abstract][Full Text] [Related]
19. Blood glucose-lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice.
Loffler M; Bilban M; Reimers M; Waldhäusl W; Stulnig TM
J Pharmacol Exp Ther; 2006 Feb; 316(2):797-804. PubMed ID: 16260581
[TBL] [Abstract][Full Text] [Related]
20. PPARγ activation induces acute PAI-1 gene expression in the liver but not in adipose tissues of diabetic model mice.
Oishi K; Tomita T; Itoh N; Ohkura N
Thromb Res; 2011 Nov; 128(5):e81-5. PubMed ID: 21757225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
